Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tianlei Ying and Ruiying Liang.
Tianlei Ying
Connection Strength
0.529
Ruiying Liang
  1. Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel). 2019 Nov 04; 8(4).
    View in: PubMed
    Score: 0.213
  2. Development of Small-Molecule MERS-CoV Inhibitors. Viruses. 2018 12 17; 10(12).
    View in: PubMed
    Score: 0.200
  3. Recent advances in developing small-molecule inhibitors against SARS-CoV-2. Acta Pharm Sin B. 2021 Jul 02.
    View in: PubMed
    Score: 0.060
  4. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal Transduct Target Ther. 2020 09 22; 5(1):212.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.